{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:06:16Z","timestamp":1788206776589,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>A combination of methylprednisolone sodium succinate (MSS) and granisetron hydrochloride (GH) is generally devoted to treating the chemotherapy-induced nausea and vomiting. To date, none of these novel mixtures have been commercially available. The present study was aimed at investigating physical and chemical compatibility and stability of a combination of MSS with GH in 0.9% sodium chloride injection for 72 hours at 4\u00b0C and 25\u00b0C.<\/jats:p>\n          <jats:p>A mixture of MSS (0.4\u20130.8\u2009mg\/mL) with GH (0.03\u2009mg\/mL) was prepared and stored in both polyvinyl chloride bags and glass bottles using 0.9% sodium chloride injection as a diluent. The study was performed using a validated and stability-indicating high-performance liquid chromatography method. The physical compatibility was assessed by a spectrometer. Furthermore, the pH measurement of each sample was measured electronically.<\/jats:p>\n          <jats:p>All test solutions stored at 4\u00b0C or 25\u00b0C had a no &gt;2% loss of the initial concentration throughout the 72-hour study period. All solutions remained clear and colorless throughout the study and were without precipitation or turbidity in any of the batches.<\/jats:p>\n          <jats:p>The drug mixtures of MSS (0.4\u20130.8\u2009mg\/mL) and GH (0.03\u2009mg\/mL) in 0.9% sodium chloride injections were physically and chemically stable for at least 72 hours when stored at 4\u00b0C or 25\u00b0C in polyvinyl chloride bags or glass bottles.<\/jats:p>","DOI":"10.1097\/md.0000000000029674","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:19:59Z","timestamp":1662650399000},"page":"e29674","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-5936","authenticated-orcid":false,"given":"Zhilei","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"Suppl 14","key":"R1-20250504","first-page":"S259","article-title":"Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies","volume":"23","author":"Adel","year":"2017","journal-title":"Am J Manag Care"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2017.10.057","article-title":"Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride","volume":"22","author":"Wu","year":"2018","journal-title":"Int J Pharm Compd"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00431-018-3218-7","article-title":"Managing cyclic vomiting syndrome in children: beyond the guidelines","volume":"177","author":"Li","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.119.257519","article-title":"Modeling corticosteroid pharmacokinetics and pharmacodynamics, part I: determination and prediction of dexamethasone and methylprednisolone tissue binding in the rat","volume":"370","author":"Ayyar","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/00016480701558906","article-title":"The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration","volume":"128","author":"Yang","year":"2008","journal-title":"Acta Otolaryngol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/acs.molpharmaceut.8b00953","article-title":"Drug solubilization by mixtures of cyclodextrins: additive and synergistic effects","volume":"16","author":"Sch\u00f6nbeck","year":"2019","journal-title":"Mol Pharm"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e3824","DOI":"10.1097\/MD.0000000000003824","article-title":"Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration","volume":"95","author":"Fang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/DDDT.S244439","article-title":"Stability and compatibility of ramosetron with midazolam in 0.9% sodium chloride injection for postoperative nausea and vomiting administration","volume":"14","author":"Xia","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clinthera.2020.01.017","article-title":"Y-site administration of imipenem\/cilastatin\/relebactam with common intravenous medications","volume":"42","author":"Ghazi","year":"2020","journal-title":"Clin Ther"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajhp\/54.1.56","article-title":"Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(98)00324-X","article-title":"Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.","volume":"177","author":"Vermeire","year":"1999","journal-title":"Int J Pharm"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00280-013-2201-2","article-title":"Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids","volume":"72","author":"Sun","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"R13-20250504","first-page":"170","article-title":"Efficacy of the granisetron\/solumedrol combination in the control of drug-induced acute nausea and vomiting. Results of a prospective survey","volume":"53","author":"Debrix","year":"1995","journal-title":"Ann Pharm Fr"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2146\/ajhp100606","article-title":"Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration","volume":"68","author":"Singh","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.2147\/DDDT.S248209","article-title":"Physical compatibility and chemical stability of fentanyl and naloxone hydrochloride in 0.9% sodium chloride injection solution for patient-controlled analgesia administration","volume":"14","author":"Chen","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2174\/1570159X17666190320164223","article-title":"Drug treatment of trichotillomania (Hair-pulling disorder), excoriation (Skin-picking) disorder, and nail-biting (Onychophagia)","volume":"17","author":"Sani","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"Suppl 5","key":"R17-20250504","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N Engl J Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00520-016-3313-0","article-title":"2016 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy","volume":"25","author":"Herrstedt","year":"2017","journal-title":"Support Care Cancer"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1136\/ejhpharm-2018-001693","article-title":"Compatible stability of methylprednisolone sodium succinate and tropisetron in 0.9% sodium chloride injection","volume":"27","author":"Peng","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2146\/ajhp110208","article-title":"Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate","volume":"69","author":"D\u2019Hondt","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"R22-20250504","first-page":"1237","article-title":"Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection","volume":"48","author":"Strom","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"R23-20250504","first-page":"2157","article-title":"Stability of diluted methylprednisolone sodium succinate injection at two temperatures","volume":"51","author":"Nahata","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1331\/108658002762063718","article-title":"Stability of methylprednisolone sodium succinate in autodose infusion system bags","volume":"42","author":"Trissel","year":"2002","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clnu.2003.09.009","article-title":"Methylprednisolone sodium succinate in pediatric parenteral nutrition: influence of vehicle injection","volume":"23","author":"Gellis","year":"2004","journal-title":"Clin Nutr"},{"key":"R26-20250504","first-page":"389","article-title":"The issue of methylprednisolone sodium succinate dosage for use","volume":"49","author":"Zhang","year":"2011","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chroma.2007.03.034","article-title":"Principles of qualitative analysis in the chromatographic context","volume":"1158","author":"Valc\u00e1rcel","year":"2007","journal-title":"J Chromatogr A"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2146\/ajhp040446","article-title":"Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers","volume":"62","author":"Bougouin","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1331\/108658002763316851","article-title":"Stability of three cephalosporin antibiotics in AutoDose Infusion System bags","volume":"42","author":"Xu","year":"2002","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/ajhp\/61.18.1928","article-title":"USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy","volume":"61","author":"Kastango","year":"2004","journal-title":"Am J Health Syst Pharm"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:14:56Z","timestamp":1746332096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":30,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029674","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}